Health Highlights: April 28, 2010 (HealthDay)
Thursday, April 29th, 2010HealthDay – Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
HealthDay – Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
HealthDay – Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
HealthDay – WEDNESDAY, April 28 (HealthDay News) — The first device that
uses radiofrequency energy to help control lung inflammation in adults
with severe chronic asthma has been approved by the U.S. Food and Drug
Administration.
HealthDay – WEDNESDAY, April 28 (HealthDay News) — The first device that
uses radiofrequency energy to help control lung inflammation in adults
with severe chronic asthma has been approved by the U.S. Food and Drug
Administration.
HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy
of ClinicalConnection.com:
HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy
of ClinicalConnection.com:
HealthDay – WEDNESDAY, April 28 (HealthDay News) — Doctors can detect more serious
precancerous lesions in the cervix by testing for human papillomavirus
(HPV) than through conventional cervical screening with a Pap smear, a new
study suggests.
HealthDay – WEDNESDAY, April 28 (HealthDay News) — Doctors can detect more serious
precancerous lesions in the cervix by testing for human papillomavirus
(HPV) than through conventional cervical screening with a Pap smear, a new
study suggests.
HealthDay – WEDNESDAY, April 28 (HealthDay News) — The Action to Control
Cardiovascular Risk in Diabetes (ACCORD) study was abruptly halted in 2008
when researchers noticed an increase in deaths in the group of type 2
diabetics who were being intensively treated to bring their blood sugar
levels down to near-normal levels.
HealthDay – WEDNESDAY, April 28 (HealthDay News) — The Action to Control
Cardiovascular Risk in Diabetes (ACCORD) study was abruptly halted in 2008
when researchers noticed an increase in deaths in the group of type 2
diabetics who were being intensively treated to bring their blood sugar
levels down to near-normal levels.